Theravance Biopharma, Inc.

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP TBPH

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/14/2026

Shares

327,546

Value ($000)

5,316

Weight

0.0%

2025 Q1 - 2026 Q1 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/14/2026	5,316	0.0%	327,546	3/31/2026
2025 Q4	2/13/2026	18,023	0.0%	963,257	12/31/2025
2025 Q3	11/13/2025	10,611	0.0%	726,783	9/30/2025
2025 Q1	5/14/2025	1,978	0.0%	221,469	3/31/2025